Challenges of pharmacovigilance automation

October 15, 2021

Challenges of pharmacovigilance automation

The development of information technology is significantly ahead of the development of regulatory and other legislation. Despite the obvious benefits of introducing new technologies in electronic systems for pharmacovigilance, it is necessary to consider the difficulties that a company will face:

Validation and audits completion

  • New approaches need to be developed to ensure quality, pass user acceptance testing, provide evidence of the validated status of the electronic system during an audit, and that the company has full control over its electronic system, regardless of the level and method of automation used in it.

Personal data management

  • It is necessary that legislation on the protection of personal data (for example, GDPR in Europe) is strictly observed in relation to new systems

Personnel training, possible changes in the organizational structure of the company

  • The introduction of new technologies will require new competencies from the staff of the pharmacovigilance and quality assurance departments
  • The introduction of new technologies may require company restructuring and additional resources

When we developed the Pharmacovigilance module, we considered all possible difficulties and propose the following solutions:

  • Flex Databases system is validated, we provide clients with a package of validation documents to prove the status of the system, as well as assistance in passing user acceptance testing
  • We strictly comply with the legislation on personal data and comply with all international and local regulations
  • For a painless and effective start of work with our system, during the implementation of the module, Flex Databases product specialists conduct detailed training on working with the system for employees of the client company

The entire pharmacovigilance process, from receiving the message to reporting and identifying safety signals, can be automated, thereby limiting the amount of human intervention that will still be required for exception handling, quality assurance, and analysis. Usage of automation is costly, but it will reduce data-processing costs, eliminate the potential for human error, and improve data quality and accuracy.

If you are interested in pharmacovigilance automation and want to learn more about the Flex Databases system – write to us at bd@flexdatabases.com or send a request for a demo through the form in the header of the page.

Blog

September 2, 2025
What CROs Should Look for in CTMS and eTMF During a Tender

When preparing a tender for a Clinical Trial Management System (CTMS) and an electronic Trial Master File (eTMF), CROs must choose solutions that meet sponsor expectations and improve operational efficiency while keeping studies inspection-ready. The right choice affects study delivery, compliance, and client satisfaction. Below are the key factors CROs should consider. Regulatory Compliance and […]

August 28, 2025
Integrations in Clinical Trials: An IT/ETL Perspective

How Flex Databases connects your study ecosystem – reliably, securely, and at scale.  Why integrations matter to sponsors and CROs  Integration means that data entered once in a system of record is propagated automatically wherever it is needed. For clinical operations teams this translates into:  Core integration patterns we see most often  1) EDC → […]

August 14, 2025
Key Changes to EU Pharmacovigilance Regulation: What You Need to Know

In July 2025, the European Commission adopted Commission Implementing Regulation (EU) 2025/1466, amending Regulation (EU) No 520/2012. The changes aim to strengthen pharmacovigilance, reduce unnecessary administrative burden, and align EU requirements with global best practices. Most provisions apply from 12 February 2026, with certain Eudravigilance updates taking effect in August 2025. Why the Changes Were […]

July 31, 2025
How Much ROI Can You Expect from eTMF and CTMS? 

A Comparative Look at Europe vs. US Markets  In clinical operations, time is money – but how much money can technology really save you? We analyzed the return on investment (ROI) for implementing electronic Trial Master File (eTMF) and Clinical Trial Management Systems (CTMS) based on real-world benchmarks. By modeling savings from reduced manual effort, […]

Contact us

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.